| Estimating the lung cancer mortality benefit of screening within lung cancer risk strata in the National Lung Screening Trial |
Hormuzd Katki |
NCI |
NLST |
Apr 30, 2012 |
201204-0017 |
| Estimating the optimal positivity criterion for lung cancer screening with low-dose computed tomography: A decision modeling approach |
Rowan Iskandar |
Brown University |
NLST |
Jan 7, 2019 |
NLST-467 |
| Estimating the probability of overdiagnosis in PLCO trial |
Jian-Lun Xu |
NCI |
PLCO |
Mar 25, 2020 |
PLCO-600 |
| Estimation of Mean Sojourn and Lead Time and Sensitivity in the Ovarian Component of the PLCO Trial |
Jian-Lun Xu |
NCI, DCP, BRG |
PLCO |
Oct 22, 2010 |
2010-0077 |
| Estimation of Measurement Error for Self-Reported Physical Activity |
Mithat Gonen |
Memorial Sloan Kettering Cancer Center |
IDATA |
Oct 19, 2016 |
IDATA-6 |
| Estimation of natural progression and survival rates for lung cancer based on NLST project |
Sherry Yueh-Hsia CHIU |
Chang Gung University |
NLST |
Apr 17, 2018 |
NLST-358 |
| Estimation of Overdiagnosis Bias in the NLST |
Edward Patz, Jr. |
Duke University Medical Center |
NLST |
Jul 27, 2012 |
201207-0026 |
| Estimation of sensitivity of chest x-ray and cancer preclinical sojourn time for the lung component of the PLCO trial |
Ping Hu |
NCI, DCP, BRG |
PLCO |
Oct 22, 2010 |
2010-0076 |
| Estrogen Exposure and Pancreatic Cancer Risk |
Timothy Donahue |
UCLA |
PLCO |
Nov 3, 2021 |
PLCO-850 |
| Ethnic and molecular diversity in prostate cancer |
Lisa Smith |
University of Nebraska at Omaha |
PLCO |
Feb 26, 2024 |
PLCO-1488 |
| Ethnic differences in colorectal cancer incidence: the role of lifestyle risk factors |
Ivana Kulhanova |
Faculty of Science, Charles University |
PLCO |
Aug 29, 2019 |
PLCO-507 |
| Ethnicity bias in automated chest X-ray classification |
Giovanni Montana |
University of Warwick |
PLCO |
Sep 6, 2022 |
PLCOI-1042 |
| Etiologic Studies: Overall Design of Study (Risk Factors for Screen Detected Adenoma) |
Richard Hayes |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0126 |
| Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for lung cancer patients |
Erin Stewart |
Artera Inc |
NLST |
May 30, 2023 |
NLST-1060 |
| Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for lung cancer patients |
Erin Stewart |
Artera |
PLCO |
May 30, 2023 |
PLCOI-1229 |
| Evaluate performance of the PreciseDx AI-digital LDT Breast assay to predict breast cancer recurrence using clinical data and H&E images from study patients |
Michael Donovan |
University of Miami |
PLCO |
Mar 9, 2021 |
PLCOI-741 |
| Evaluate the impact of ovarian cancer interventions for primary prevention, screening and treatment |
Iakovos Toumazis |
The University of Texas MD Anderson Cancer Center |
PLCO |
Nov 17, 2020 |
PLCO-689 |
| Evaluating a multi-biomarker panel for the early detection of ovarian cancer |
Maxwell Akonde |
University of South Carolina |
PLCO |
Apr 8, 2022 |
PLCO-966 |
| Evaluating cancer mortality in the National Lung Screening Trial |
Chiung-Yu Huang |
Johns Hopkins University |
NLST |
Apr 18, 2014 |
NLST-69 |
| Evaluating circulating immunologic markers in the development of multiple myeloma |
Jonathan Hofmann |
NCI |
PLCO |
Mar 16, 2018 |
PLCO-355 |
